Last reviewed · How we verify
Low Dose Enoxaparin
Low Dose Enoxaparin is a Small molecule drug developed by Oregon Health and Science University. It is currently FDA-approved. Also known as: Lovenox, enoxaparin, Clexane.
At a glance
| Generic name | Low Dose Enoxaparin |
|---|---|
| Also known as | Lovenox, enoxaparin, Clexane |
| Sponsor | Oregon Health and Science University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO (PHASE2)
- Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management (NA)
- A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty (PHASE3)
- A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants (PHASE2)
- A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants (PHASE1)
- Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis (PHASE3)
- AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (PHASE3)
- Comparison of Apixaban Versus Enoxaparin (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Low Dose Enoxaparin CI brief — competitive landscape report
- Low Dose Enoxaparin updates RSS · CI watch RSS
- Oregon Health and Science University portfolio CI
Frequently asked questions about Low Dose Enoxaparin
What is Low Dose Enoxaparin?
Low Dose Enoxaparin is a Small molecule drug developed by Oregon Health and Science University.
Who makes Low Dose Enoxaparin?
Low Dose Enoxaparin is developed and marketed by Oregon Health and Science University (see full Oregon Health and Science University pipeline at /company/oregon-health-and-science-university).
Is Low Dose Enoxaparin also known as anything else?
Low Dose Enoxaparin is also known as Lovenox, enoxaparin, Clexane.
What development phase is Low Dose Enoxaparin in?
Low Dose Enoxaparin is FDA-approved (marketed).
Related
- Manufacturer: Oregon Health and Science University — full pipeline
- Also known as: Lovenox, enoxaparin, Clexane
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing